Novartis Fact Sheet, Novartis Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Novartis Fact Sheet    (NVRT)


REVEALED: 3 "Super Smallcaps" You Didn't Know About


Here is the latest financial fact sheet of Novartis. For more details, see the Novartis quarterly results and Novartis share price and chart. For a sector overview, read our pharmaceuticals sector report.

NOVARTIS Price History

Price Rs 841.8
Mkt Cap Rs m 20,785
Vol '000 0.0
P/E X 91.2
P/CF X 62.9
EPS (TTM) Rs 9.2
% ch % 0.5
No. of shares m 24.69
% ch week % 1.5
% ch 1-mth % -1.2
% ch 12-mth % 29.1
52 week H/L Rs 1,099.0/538.1
(As on Sep 17, 2021 09:19:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NOVARTIS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
NOVARTIS EQUITY SHARE DATA
High Rs855758980780770 
Low Rs630579600420501 
Sales per share (Unadj.) Rs233.2228.4198.7177.5154.5 
Earnings per share (Unadj.) Rs20.331.721.04.18.5 
Diluted earnings per shareRs23.231.721.04.18.5 
Cash flow per share (Unadj.) Rs21.632.822.39.413.4 
Dividends per share (Unadj.) Rs10.0010.0010.0010.0010.00 
Adj. dividends per shareRs11.4010.0010.0010.0010.00 
Avg Dividend yield %1.31.51.31.71.6 
Book value per share (Unadj.) Rs329.4299.6309.2293.2289.2 
Adj. book value per shareRs375.5299.6309.2293.2289.2 
Shares outstanding (eoy) m28.1424.6924.6924.6924.69 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x3.22.94.03.44.1 
Avg P/E ratio x36.521.137.7147.075.1 
P/CF ratio (eoy) x34.420.435.563.847.5 
Price / Book Value ratio x2.32.22.62.02.2 
Dividend payout %49.231.547.7244.9118.1 
Avg Mkt Cap Rs m20,89416,50619,50814,81515,691 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,3931,4451,1711,1391,085 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
NOVARTIS INCOME DATA
Net Sales Rs m6,5625,6394,9074,3833,814 
Other income Rs m7151,738784364332 
Total revenues Rs m7,2777,3775,6914,7474,146 
Gross profit Rs m245-82121117267 
Depreciation Rs m362532131122 
Interest Rs m755166477 
Profit before tax Rs m9171,575858286400 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m345792340186191 
Profit after tax Rs m572784518101209 
Gross profit margin %3.7-1.52.52.77.0 
Effective tax rate %37.650.339.664.847.8 
Net profit margin %8.713.910.62.35.5 
NOVARTIS BALANCE SHEET DATA
Current assets Rs m11,11511,0439,8879,9739,224 
Current liabilities Rs m3,2324,8173,6724,1693,573 
Net working cap to sales %120.1110.4126.7132.4148.2 
Current ratio x3.42.32.72.42.6 
Inventory Days Days530650754136176 
Debtors Days Days2328343137 
Net fixed assets Rs m9,58910,08910,2922,3982,480 
Share capital Rs m141123123123123 
"Free" reserves Rs m9,1307,2757,5117,1177,018 
Net worth Rs m9,2717,3987,6347,2407,141 
Long term debt Rs m00000 
Total assets Rs m20,70421,13120,17912,37011,703 
Interest coverage x128.429.554.95.56.2 
Debt to equity ratio x00000 
Sales to assets ratio x0.30.30.20.40.3 
Return on assets %2.84.02.61.32.4 
Return on equity %6.210.66.81.42.9 
Return on capital %10.022.011.44.86.7 
Exports to sales %2.01.11.26.19.3 
Imports to sales %00000 
Exports (fob) Rs m1296158269354 
Imports (cif) Rs m00000 
Fx inflow Rs m1296158269354 
Fx outflow Rs m1,7343,6301,3261,420974 
Net fx Rs m-1,605-3,570-1,269-1,152-621 
NOVARTIS CASH FLOW
From Operations Rs m -408 1,610 -1,943 -231 -692 
From Investments Rs m 4,236 687 2,742 559 952 
From Financial Activity Rs m -3,318 -2,677 -298 -414 -368 
Net Cashflow Rs m 510 -380 501 -86 -109 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 70.7%
Institution 0.9%
Non-Institution 28.4%
Total 100.0%
Free Float 29.3%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF The Inspire B K C Part Of 601 & 701, Bandra Kurla Complex, Bandra East, Mumbai - 400051
E-MAIL india.investors@novartis.com WEB www.novartis.in
TEL 022-24958400 / 24958888/5024 3000 FAX 022-24950221/5024 3010
SECTOR TRADING GROUP Novartis India - MNC
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
AUDITOR Lovelock and Lewes
CHM: C. Snook COMP SEC: Girish Tekchandani YEAR OF INC: 1947 BSE CODE: 500672 FV (Rs): 5 DIV YIELD (%): 1.2

More Trading Company Fact Sheets:   ASHRAM ONLINE  AASHKA HOSPITALS  SEQUENT SCIENTIFIC  BRAWN BIOTECH  ZENLABS ETHICA  

Compare NOVARTIS With:   ASHRAM ONLINE  AASHKA HOSPITALS  SEQUENT SCIENTIFIC  BRAWN BIOTECH  ZENLABS ETHICA  




Today's Market

SGX Nifty Up 84 Points; Indicates Firm Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a positive note today. At 8:10 am, it was trading up by 84 points, or 0.5% higher at 17,695 levels.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

Revenge Travel is Here. 9 Stocks Likely to Benefit (Views On News)

Sep 4, 2021

The term 'revenge travel' refers to the desire of going on a vacation after an extended period of lockdown.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS - TOHEAL PHARMA COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS